Multiple Sclerosis Lupus Rheumatoid Arthritis Celiac Disease Coeliac Disease Myasthenia Gravis Type 1 Diabetes Thyroid Disorders Stiff-Person Syndrome Hashimoto's Disease
The result suggests a drug that blocks the immune protein IL‑15 could become the first therapy to protect celiac patients from accidental gluten exposure and will move into larger trials.